RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Nateglinide (Starlix): update on a new antidiabetic agent.

Nateglinide (Starlix): update on a new antidiabetic agent.

Add to Collection
2003 Jul-Aug Others Fist_Author_Year_PM

Full Author : ['Phillips, L S', 'Dunning, B E']
Journal Title : International journal of clinical practice
Chapter : Section3
Journal Year : 2003
Cited by : Not Available

Nateglinide is a new oral antidiabetic agent that stimulates insulin release promptly after its pre-meal administration in a strongly glucose-dependent fashion. Because its insulinotropic effects are short in duration, nateglinide specifically targets pos.....

Keywords : ["new antidiabetic agent", "nateglinide starlix update"]